Discover how a groundbreaking approach using a histamine blocker achieved complete remission in a challenging case of hyperadrenergic postural orthostatic tachycardia syndrome, offering new hope for patients suffering from long-term effects of COVID-19.
– by Klaus
Note that Klaus is a Santa-like GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Complete remission with histamine blocker in a patient with intractable hyperadrenergic postural orthostatic tachycardia syndrome secondary to long coronavirus disease syndrome.
González-Alvarez et al., J Hypertens 2024
<!– DOI: 10.1097/HJH.0000000000003669 //–>
https://doi.org/10.1097/HJH.0000000000003669
Ho, ho, ho! Gather around, my dear friends, for I have a tale to tell, not of elves and reindeer, but of a challenge that has swept across our global village, much like the blizzards of the North Pole. This tale is about the COVID-19 pandemic, caused by a rather naughty virus known as SARS-CoV-2. Just when we thought the storm was passing, the sequels of this pandemic, much like the endless lists of who’s been naughty or nice, have started to outcrop.
In this story, a good number of folks who battled with COVID-19 find themselves facing a rather pesky aftermath, known in the medical world as long-COVID or post-COVID condition (PCC). Imagine, if you will, a sack full of mixed gifts; that’s PCC for you, a multisystemic, heterogeneous, chronic disorder. Among the myriad of surprises it brings, cardiovascular and neurological symptoms shine the brightest, much like Rudolph’s red nose on a foggy night.
Indeed, a peculiar guest, dysautonomia, has made its way into the limelight, presenting as orthostatic intolerance. This is akin to feeling dizzy and out of sorts when standing up too quickly after a long night of making toys. Recent whispers in the medical community have linked this dizziness, known as postural orthostatic tachycardia syndrome (POTS), with PCC. The main culprits here are disturbances in heart rate (HR) and blood pressure (BP) during postural changes, making patients feel as if they’re riding on a sleigh without reins.
Now, let’s sprinkle a bit of magic dust on a subtype of POTS, known as hyperadrenergic POTS, which has been the subject of many a curious elf due to its association with mast cell activation syndrome (MCAS). While the connection between PCC, hyperadrenergic POTS, and MCAS remains as mysterious as the exact location of Santa’s workshop, it’s believed these syndromes can overlap, much like the overlapping of wrapping paper when elves are in a hurry.
So, my dear friends, we propose a correlation as intriguing as the idea of reindeer flying, a close-loop mechanism with positive feedback established after a SARS-CoV-2 infection in a previously healthy young patient. Just as we prepare for Christmas every year, understanding this connection could help us better prepare for and manage the aftermath of this global health challenge. Merry insights to all, and to all a good night!